Search the GHTC website

Global health R&D delivers for Indiana

US government investment in global health R&D has delivered

$48.8 million
to Indiana research institutions
600+ new jobs
for Indiana
Global health R&D at work in Indiana

University of Notre Dame researchers are studying the use of spatial repellents to prevent mosquito-borne diseases. Spatial repellents release chemicals (a common example is a mosquito candle) and can help stop the spread of disease where existing tools such as bednets and indoor residual spraying are not entirely effective. New strategies are needed to avert the more than 50 million cases of dengue and 200 million cases of malaria that occur each year. The project will generate data to inform disease control programs.

  • Methodology
  • USG global health R&D investment to state research institutions/Top USG-funded global health R&D institutions: Authors' analysis of USG investment data from the G-FINDER survey, including funding for R&D for neglected diseases from 2007–2015 and for Ebola and select viral hemorrhagic fevers from 2014–2015. Reflects USG funding received by entities in state including academic and research institutions, product development partnerships, other nonprofits, select corporations, and government research institutions, as well as self-funding or other federal agency transfers received by federal agencies located in state; but excludes pharmaceutical industry data which is aggregated and anonymized in the survey for confidentiality purposes. See methodology for additional details.
  • Jobs created: Based on previous analysis of the economic impact of National Institutes of Health R&D funding and author's analysis described above. See methodology for additional details.
  • Case study photo: Flickr/Sesai Ministério da Saúde